Mesoblast (MESO) Revenue (2014 - 2023)

Mesoblast (MESO) has reported Revenue for 10 consecutive years, with $1.9 million the latest figure, recorded in Q2 2023.

• Quarterly Revenue fell 16.59% year-over-year to $1.9 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $8.1 million (down 20.07% YoY) and the FY2025 annual result came in at $17.2 million, up 191.39% from the prior year.
• Revenue declined to $1.9 million in Q2 2023 per MESO's latest filing, from $1.9 million in the prior quarter.
• Over the last five years, Revenue for MESO reached as high as $26.6 million in Q2 2020 and fell as low as $1.0 million in Q1 2019.
• A 5-year average of $3.5 million and a median of $2.0 million in 2020 frame the typical range for Revenue.
• Annual changes were most pronounced in 2020 — Revenue soared 1251.14% — and 2021, when it slumped 87.69%.
• Year by year, Revenue stood at $2.0 million in 2019, then rose by 13.81% to $2.2 million in 2020, then surged by 57.79% to $3.5 million in 2021, then sank by 39.65% to $2.1 million in 2022, then retreated by 13.07% to $1.9 million in 2023.
• According to Business Quant data, Revenue over the past three periods registered $1.9 million, $1.9 million, and $2.1 million for Q2 2023, Q1 2023, and Q4 2022 respectively.